SUBSCRIBE
SUBSCRIBE

CuraSen

NEWS
Business
Three Biopharma Companies Bolster Leadership Teams
Silence Therapeutics, Totus Medicines and Poseida Therapeutics all adjust as they welcome new members to their leadership teams.
February 23, 2022
 · 
2 min read
 · 
Alex Keown
Business
Top Life Sciences Startups to Watch in 2020
BioSpace is proud to present its NextGen Bio “Class of 2020,” a list of up-and-coming life science companies in North America that launched no earlier than mid-2018.
January 3, 2020
 · 
13 min read
 · 
Mark Terry
IN THE PRESS
Business
CuraSen Therapeutics Appoints Kathleen Sereda Glaub Chief Executive Officer
October 15, 2024
 · 
5 min read
Drug Development
CuraSen Therapeutics Announces Oral Presentation of Additional Positive Phase 2a Data with CST-2032/CST-107 in Patients with Alzheimer’s or Parkinson’s Disease at AD/PD™ 2024 International Conference
March 7, 2024
 · 
5 min read
Drug Development
CuraSen Therapeutics Presents Phase 1b Clinical Data with CST-103 Demonstrating Significant Increases in Cerebral Blood Flow in Patients with Mild Cognitive Impairment or Parkinson’s Disease
November 9, 2021
 · 
5 min read
Business
CuraSen Therapeutics Expands Management Team; Appoints Peter Butera as Senior Vice President, Operations
September 10, 2019
 · 
3 min read
Business
CuraSen Therapeutics Expands Management Team; Industry Veteran and Neuroscience Expert Gabriel Vargas, MD, PhD, Appointed to Chief Medical Officer
November 1, 2018
 · 
2 min read
Business
CuraSen Therapeutics Announces $54.5 Million Series A Financing with Industry Veterans at Helm to Develop Drugs Targeting Novel Mechanism for the Treatment of Neurodegenerative Diseases
October 17, 2018
 · 
3 min read
AWARDS
  • NextGen Class of 2020
JOBS